EUVIMEDEUVIMED entdecken
Crossref

The role of colposcopy in the clinical diagnosis and management of cytology-negative, non-16/18 high-risk HPV positive patients

Neçirvan Çağdaş Çaltek, Mahmut Yassa, Gözde Şahin, Başak Özge Kayan, İlteriş Yaman, İlkbal Temel

Journal of Medicine and Palliative Care · 25.06.2026 · 7 (3) · 504-508

DOI: 10.47582/jompac.1908071 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medicine and Palliative Care, online erschienen am 25.06.2026. Verfasst von Neçirvan Çağdaş Çaltek und 5 weiteren Autor:innen. Die Arbeit nennt 27 Literaturangaben. Gefördert von: This research received no external funding..

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

To evaluate the diagnostic and therapeutic role of colposcopy in patients with negative cervical cytology but positive for high-risk human papillomavirus (hrHPV) types other than HPV 16 and 18, in light of current guideline recommendations.

Methods

This retrospective study included 428 women aged 21-65 who underwent colposcopy at a tertiary care center between June 2020 and December 2024. All patients had negative cytology and tested positive exclusively for high-risk HPV types other than HPV 16/18. Cervical biopsy and endocervical curettage (ECC) were performed during colposcopy. Histopathological evaluations were conducted by experienced gynecologic pathologists using the Lower Anogenital Squamous Terminology (LAST) system. Demographic and clinical data were recorded and analyzed using SPSS version 27.

Results

Among the 428 patients, 281 (65.7%) had no dysplasia, 126 (29.4%) had CIN 1, 15 (3.5%) had CIN 2, and 6 (1.4%) had CIN 3. No cases of invasive cervical cancer were detected. ECC results showed CIN 1 lesions in 11 patients (2.6%) and no high-grade lesions. The overall rate of CIN2+ lesions was 4.9%. Most patients with CIN2+ lesions were multiparous, premenopausal, and had a mean age of 40 years.

Conclusion

Current ASCCP guidelines recommend follow-up with co-testing after one year for patients with negative cytology and non-16/18 hrHPV positivity. However, the 4.9% rate of CIN2+ lesions observed in this study suggests that immediate colposcopy may be clinically beneficial in this patient group. Especially in populations with low adherence to follow-up, colposcopy may represent an alternative management approach.

Förderung

  • This research received no external funding.

Zitieren

APA

Çaltek, N. Ç., Yassa, M., Şahin, G., Kayan, B. Ö., Yaman, İ., & Temel, İ. (2026). The role of colposcopy in the clinical diagnosis and management of cytology-negative, non-16/18 high-risk HPV positive patients. Journal of Medicine and Palliative Care, 7(3), 504-508. https://doi.org/10.47582/jompac.1908071

Vancouver

Çaltek NÇ, Yassa M, Şahin G, Kayan BÖ, Yaman İ, Temel İ. The role of colposcopy in the clinical diagnosis and management of cytology-negative, non-16/18 high-risk HPV positive patients. Journal of Medicine and Palliative Care. 2026;7(3):504-508. doi:10.47582/jompac.1908071

BibTeX
@article{altek2026,
  author = {Çaltek, Neçirvan Çağdaş and Yassa, Mahmut and Şahin, Gözde and Kayan, Başak Özge and Yaman, İlteriş and Temel, İlkbal},
  title = {The role of colposcopy in the clinical diagnosis and management of cytology-negative, non-16/18 high-risk HPV positive patients},
  journal = {Journal of Medicine and Palliative Care},
  year = {2026},
  volume = {7},
  number = {3},
  pages = {504--508},
  doi = {10.47582/jompac.1908071}
}
Kostenlos starten →